Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Pfizer Inc.    PFE   US7170811035

PFIZER INC.

 (PFE)

181
Real-time Quote. Real-time BATS US - 05/17 04:59:59 pm
29.005 USD   -0.84%
5d agoDJNovartis Considers Possible Bid for Actavis
5d agoDJPair of Studies Show Power of Immune System to Fight Cancer
5d ago PFIZER INC.: StockCall Scrutinizes PFE, MRK, JNJ, ABBV, and ZGNX
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisionsForum 

Pfizer Inc. : St. Louis-based Carey, Danis & Lowe Announces Suit Against the Maker of Zoloft Sent Back to St. Louis Circuit Court

04/11/2012| 05:58pm US/Eastern
Recommend:
0

Pfizer's attempt to litigate lawsuit in federal court rebuffed

St. Louis-based law firm Carey, Danis & Lowe announces a lawsuit against Pfizer Inc. (NYSE: PFE), maker of the antidepressant drug Zoloft, that was originally filed in St. Louis Circuit Court then removed to federal court by the drugmaker, has been ordered back to the state court.

The lawsuit, Shainyah Lancaster, et al. v. Pfizer, Inc., cause no. 1222-CC00766, was filed on Feb. 2 in St. Louis Circuit Court on behalf of 21 children born with defects after their mothers were prescribed Zoloft while pregnant. The suit was brought on behalf of the plaintiffs by the law firms of Carey, Danis & Lowe; Matthews & Associates; Freese & Goss; and Clark, Burnett, Love & Lee.

On March 8, Pfizer removed the case to the U.S. District Court for the Eastern District of Missouri alleging that diversity of citizenship existed between the plaintiffs and the defendant. The lawyers representing the plaintiffs opposed the effort to remove the case to federal court. (S.L., et al. v. Pfizer, Inc., Case 4:12-cv-00420).

On April 4, U.S. District Judge Carol E. Jackson sided with the plaintiffs and ruled that the federal court did not have jurisdiction over the lawsuit because complete diversity of citizenship did not exist, granted the plaintiffs' motion to remand and sent the case back to St. Louis Circuit Court for further proceedings.

Zoloft (generic name sertraline) belongs to a class of drugs known as selective serotonin reuptake inhibitors, or SSRIs. The suit notes that SSRIs have been found to cause severe birth defects in the children of women who were prescribed the drug while pregnant and alleges that Pfizer knew or should have known that children born to mothers who had taken SSRIs during pregnancy had a greater risk of congenital birth defects and that despite knowing that physicians were prescribing Zoloft to women of childbearing age, Pfizer failed to adequately warn the medical community and the public of the danger.

The lawsuit asserts state law claims against Pfizer of negligence; negligence of pharmacovigilance, which requires Pfizer to monitor safety data for its drugs; strict liability; negligent design; failure to warn; and fraud. The suit seeks actual and punitive damages.

Founded in 1995, Carey, Danis & Lowe has offices in Missouri and Illinois. The firm handles personal injury, pharmaceutical liability, product liability, medical malpractice, class action and commercial cases throughout the United States.

Carey, Danis & Lowe
Jeffrey J. Lowe, 800-721-2519
jlowe@careydanis.com
or
Sarah Shoemake Doles, 800-721-2519
sdoles@careydanis.com
www.careydanis.com


© Business Wire 2012
Recommend :
0
Partner Area
React to this article
 
Latest news on PFIZER INC.
5d agoDJNovartis Considers Possible Bid for Actavis
5d agoDJPair of Studies Show Power of Immune System to Fight Cancer
5d ago PFIZER INC.: StockCall Scrutinizes PFE, MRK, JNJ, ABBV, and ZGNX
7d ago PFIZER INC.: Pfizer Announces 11 Abstracts for Tofacitinib to Be Presented at t..
05/10DJPfizer Has Second Recall of Thyroid-Disorder Drug Levoxyl
05/10 Drugmakers face more scrutiny of discordant U.S. prices
05/10DJU.S. HOT STOCK FUTURES: Hot stocks to watch
05/10DJPAIN THERAPEUTICS: Pfizer Reassessing Continued Remoxy Partnership
05/08 PFIZER INC.: Pfizer Invites Public to View and Listen to Webcast of Pfizer Pres..
05/08 U.S. COMPANIES' OVERSEAS EARNINGS HI: study
Advertisement
Chart
Duration : Period :
Pfizer Inc. Technical Analysis Chart | PFE | US7170811035 | 4-Traders
Income Statement Evolution
Pfizer Inc. : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.